Researchers reported rapid, significant improvement in depression, with the benefits lasting for months after treatment.

Breakthrough study finds single dose of psychedelics significantly reduced depression symptoms in clinical trial, with effects lasting up to six months.

Compass Pathways on Tuesday disclosed results from two Phase 3 studies that support a potential approval of its psilocybin treatment for severe depression, but more detailed data are needed to ...

Discover how TMS therapy targets depression at the source. A deep dive into the physics, safety protocols, and FDA-cleared ...

A Phase IIa clinical trial finds that a single, brief dose of DMT (from ayahuasca) provides rapid and lasting relief for depression.

D-serine as an adjunctive treatment did not outperform placebo overall in patients with major depressive disorder (MDD), a new trial showed. However, depressive symptoms and anhedonia were ...

A new study found that aerobic exercise can be highly effective for reducing symptoms of depression and anxiety, with ...

Zuranolone is a novel, rapidly acting, oral medication for the treatment of postpartum depression. Zuranolone is generally ...

New hope for earlier treatment might be on the horizon for people suffering the most severe form of depression. In a study of patients watching emotionally evocative movies, the responses of people ...

Depression is a complex and deeply personal experience. While almost everyone has periods of sadness, low mood or grief, depression is different. Major depressive disorder is persistent, interferes ...

No single ‘depression gene’ has been found, but large studies have identified over 100 genetic risk markers on chromosomes ...